EPM fires some questions with Neil Ward, PacBio, to learn of the trends of 2023, and how its HiFi genome sequencing technology will be used in collaboration with Boston Children's Hospital to uncover novel mutations in rare paediatric diseases.
Nearly half of senior decision-makers working for drug development companies or manufacturers said data silos derailed the efficiency of cross-functional collaboration in their organisation.
This Saturday marked International Day of Woman and Girls in Science and Jane Kennedy, chief business officer, Discovery Park, asks why women in this sector are still excluded from funding and leadership positions.
As the life sciences sector grapples with a rapidly changing environment and increasing regulatory scrutiny, Frits Stulp of Iperion – a Deloitte business, predicts that harnessing the power of digital transformation can optimise patient outcomes.
Jason Boyd, senior director, Vault LIMS, Veeva Systems, gives three ways in which digital strategies can modernise quality control by creating a holistic view of workflow and quality data in biopharma lab operations.
Natalie DiMambro, VP product commercialisation and training, Within3, explores the technologies and trends that are causing leaders to redefine current practices and invest more heavily in innovation to stay ahead of the curve in 2023.
SHL Medical discusses the evolution of drug formulations and how it’s supporting cartridge-based subcutaneous drug delivery in redefining the field of patient self-injection.
Andrew Lee, senior consultant at lab services and consultancy specialist, Broughton, reports that packaging selection is an important consideration for many drug products, particularly pressurised metered dose inhalers (pMDIs).
Kerstin Pohl, sr. global manager, Gene Therapies, at SCIEX, and Thomas Kofoed, co-founder of Alphalyse, discussed the harmful effects of HCPs and strategies to mitigate them.
Michael Earl, director, pharmaceutical services at Owen Mumford, examines the benefits that patients are set to receive as the connected drug delivery devices market grows.
